Klemp M, Frønsdal KB, Facey K. What principles should govern the use of managed entry agreements? Int J Technol Assess Health Care. 2011 Jan;27(1):77-83.
A conditional arrangement between manufacturer and payer that enables earlier reimbursement of a health technology to address uncertainty in its performance or to manage its utilization.
Note 1: Related terms include managed entry agreement, managed entry scheme and coverage with evidence development.